NEW YORK PHARMA FORUM INC co BENCIVENGA WARD & COMPANY CPAS PC (EIN 133616157) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1991

Legal Domicile

Principal Officer

Dr John Keller

Phone

9147695005

Tax Period

2021-04-01 to 2022-03-31

NEW YORK PHARMA FORUM INC co BENCIVENGA WARD & COMPANY CPAS PC, founded in 1991, is a micro nonprofit that reported $2 in total revenue in fiscal year 2021. Revenue fell 50% from the prior year — a significant decline worth monitoring. Expenses of $1K exceeded revenue, resulting in a 67900% operating deficit.

Mission

BETTER UNDERSTANDING OF THE PHARMACEUTICAL INDUSTRY BETWEEN THE USA AND JAPAN.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2021)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $2

Other Revenue $0

TOTAL REVENUE $2

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $1,360

TOTAL EXPENSES $1,360

Year-over-Year Comparison

	2021	2020	Change
Revenue	$2	$4	-0.5%
Expenses	$1,360	$2,877	-0.5%
Net Income	$-1,358	$-2,873	-0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Mr Sang Le	Director	1.00	Director	$0	$0	$0
Mr Mitsu Kosaka	Secretary	2.00	Officer Director	$0	$0	$0
Dr Jeffrey Warmke	Director	1.00	Director	$0	$0	$0
Mr Tuyen Do	Director	1.00	Director	$0	$0	$0
Ms Theresa Covert	Director	1.00	Director	$0	$0	$0
Mr Kazumi Taguchi	Director	1.00	Director	$0	$0	$0
Dr John Keller	President	2.00	Officer Director	$0	$0	$0
Dr Toby Freyman	Director	1.00	Director	$0	$0	$0
Dr Hiroshi Kawai	Director	1.00	Director	$0	$0	$0
Dr Rana Al-Hallaq	Director	1.00	Director	$0	$0	$0
Ms Brianne Weingarten	Vice President	2.00	Officer Director	$0	$0	$0
Dr Alex Chang	Director	1.00	Director	$0	$0	$0
Mr Shoji Yasuda	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$2	$1,360	$113,374	$-1,358
2021	$4	$2,877	$113,732	$-2,873
2020	$6	$60,414	$120,855	$-60,408
2019	$175,950	$236,454	$176,639	$-60,504

NEW YORK PHARMA FORUM INC co BENCIVENGA WARD & COMPANY CPAS PC